vaccin
one
efficaci
medic
intervent
decreas
human
morbid
mortal
region
world
dramat
reduc
incid
numer
diseas
hilleman
andr
et
al
measl
diphteria
mump
rubella
tetanu
yellow
fever
pertussi
poliomyel
also
erad
dread
smallpox
viral
infect
strassburg
effort
current
also
focus
develop
vaccin
treatment
diseas
ada
triumph
infecti
diseas
achiev
use
either
kill
attenu
convent
vaccin
convent
prophylact
vaccin
base
deliber
exposur
nonvirul
form
pathogen
establish
immun
subsequ
exposur
virul
form
pathogen
lee
et
al
approach
requir
littl
knowledg
molecular
natur
individu
pathogen
antigen
immun
respons
elicit
date
approach
undoubtedli
success
howev
ongo
trend
toward
emerg
infecti
diseas
fauci
fauci
et
al
humankind
differ
part
world
diseas
caus
emerg
new
pathogen
resurg
old
one
constantli
mutat
pathogen
drugresist
pathogen
even
includ
pathogen
use
agent
bioterror
previous
undescrib
pathogen
sever
acut
respiratori
syndrom
sar
bird
flu
avian
influenza
mad
cow
hivaid
appear
increas
frequenc
hand
old
diseas
ebola
hanta
dengu
cholera
among
other
invad
popul
disappear
cross
speci
barrier
invad
new
speci
occasion
pathogen
mutat
recombin
adapt
show
new
variant
evad
host
acquir
immun
annual
influenza
epidem
gener
due
genet
drift
strain
influenza
differ
slightli
previou
strain
bouvier
pales
develop
drugresist
pathogen
malaria
pneumococci
enterococci
tuberculosi
increas
year
partli
due
widespread
inappropri
use
drug
knobler
et
al
moreov
pathogen
respons
emerg
infecti
diseas
also
potenti
use
bioterrorist
weapon
ryan
reason
emerg
infecti
diseas
continu
pose
threat
public
health
moren
fauci
therefor
need
effect
vaccin
help
reduc
human
morbid
mortal
emerg
infecti
diseas
last
decad
seen
signific
advanc
new
technolog
develop
new
vaccin
technolog
combin
understand
host
respons
foreign
antigen
laid
foundat
rapid
advanc
vaccinolog
potenti
candid
approach
new
famili
vaccin
arnon
benyedidia
minichiello
babiuk
nandi
basak
subunit
vaccin
genet
engin
live
vaccin
polynucleotid
dna
genet
vaccin
new
direct
vaccin
develop
someth
common
import
challeng
discoveri
key
antigen
array
protein
encod
pathogen
genom
abl
elicit
protect
immun
respons
pathogen
effect
major
human
popul
presenc
genet
variat
gene
host
immun
system
across
human
popul
genom
pathogen
variant
make
multidimension
combinatori
problem
sinc
focu
vaccin
design
pathogen
variabl
domain
mutant
multival
coverag
much
conserv
region
plotkin
howev
larg
bodi
data
build
field
vaccin
design
epitop
predict
point
neglect
aspect
conserv
epitop
import
target
vaccin
develop
fact
evid
accumul
mani
variabl
region
highli
antigen
suffici
larg
number
actual
nonimmunoprotect
exploit
virus
pathogen
immun
escap
may
lead
immunopatholog
haydon
woolhous
conserv
epitop
thought
unimport
due
lack
immunogen
bona
et
al
li
et
al
howev
immunogen
conserv
epitop
especi
immuneprotect
conserv
amongst
mani
variant
mutant
strain
boost
use
adjuv
chemic
approv
drug
molecul
moreov
conserv
epitop
also
help
address
issu
ethnic
panhaplotyp
respons
compar
variabl
epitop
khan
et
al
addit
conserv
epitop
circumv
vaccin
design
issu
escap
mutant
need
use
latest
strain
particular
set
conserv
immunogen
immunoprotect
epitop
suitabl
boost
elicit
mutat
pathogen
thu
reason
predict
remain
unchang
next
season
infect
possibl
extend
efficaci
vaccin
would
tremend
advanc
vaccin
industri
potenti
serv
global
popul
protect
infect
sylvesterhvid
et
al
de
groot
et
al
sett
et
al
raman
et
al
vaccin
informat
fledgl
subfield
revers
vaccinolog
potenti
develop
effect
vaccin
rapid
expans
vaccin
relat
data
host
pathogen
stem
classic
highthroughput
genomicproteom
approach
identifi
conserv
robust
immunogen
immunoprotect
epitop
manual
larg
data
pool
ineffici
vaccin
informat
practic
scienc
design
new
vaccin
focu
bioinformaticsdriven
acquisit
manipul
analysi
data
relat
immun
system
diseas
agent
raman
et
al
provid
mean
systemat
studi
big
data
prescreen
target
facilit
experiment
design
valid
small
number
key
experi
bioinformat
support
divid
two
standard
bioinformat
support
specialis
immunoinformat
support
standard
support
includ
basic
bioinformat
function
sequenc
comparison
align
databas
search
hunt
pattern
profil
analysi
model
data
annot
review
immunoinformat
target
bioinformat
support
emphasi
datawareh
mine
immunolog
data
predict
immunogen
soriaguerra
et
al
vaccin
research
take
advantag
bioinformat
approach
combin
experiment
valid
discov
facilit
better
understand
compon
human
immunom
aid
design
new
vaccin
immunom
defin
complet
set
gene
protein
immun
system
highli
accur
target
predict
diminish
discoveri
cost
fold
de
groot
et
al
kast
et
al
human
higher
vertebr
host
major
function
immun
system
mainten
homeostasi
surveil
toler
selfstructur
defenc
follow
immun
pathogen
yatim
lakki
immun
system
wide
distribut
bodi
compris
immun
organ
tissu
cell
connect
complex
tightli
regul
network
jern
nih
nicholson
gener
process
take
place
molecular
level
cellular
level
larg
initi
regul
function
immun
system
healthi
immun
system
discrimin
nonself
foreign
antigen
protein
normal
present
self
organ
rais
appropri
respons
number
selfstructur
larg
finit
number
nonself
structur
practic
infinit
cell
self
nonself
protein
digest
proteasom
short
peptid
fragment
bound
major
histocompat
complex
mhc
molecul
form
peptidemhc
complex
display
surfac
host
cell
vigneron
van
den
eynd
peptid
recognit
label
display
content
host
cell
cell
immun
system
presenc
nonself
peptid
prerequisit
initi
immun
respons
peptid
produc
degrad
intracellular
protein
bind
mhc
class
molecul
recognis
cell
receptor
shastri
et
al
chowel
et
al
blum
et
al
mhc
class
ii
molecul
present
peptid
produc
degrad
protein
extracellular
origin
surfac
antigenpres
cell
cell
review
et
al
major
function
cell
recogn
destroy
cell
infect
pathogen
nicholson
peptid
display
mhc
class
ii
molecul
mainli
serv
regul
immun
respons
crucial
initi
enhanc
suppress
immun
respons
driven
method
molecular
cell
biolog
signific
advanc
understand
immunolog
process
made
last
two
decad
progress
year
result
continu
accumul
huge
amount
immunolog
data
obtain
experiment
grow
number
immunolog
data
high
complex
function
structur
foundat
immun
process
creat
need
improv
data
manag
enabl
advanc
data
analysi
need
manag
analys
grow
amount
complex
data
led
develop
number
immunolog
databas
syfpeithi
mchpep
imgt
fimm
complex
comput
model
petrovski
brusic
purpos
immunolog
databas
facilit
collect
access
use
immunolog
relev
data
one
applic
databas
immunolog
vaccin
research
develop
use
complex
comput
model
combin
experiment
approach
help
precis
understand
antigen
present
recognit
immun
system
combin
effort
experiment
comput
immunolog
provid
us
new
perspect
design
vaccin
effect
across
demograph
boundari
previous
extrem
degre
polymorph
observ
mhc
pose
limit
develop
vaccin
abil
trigger
effect
tcell
respons
partli
determin
mhc
phenotyp
individu
differ
individu
differ
mhc
allel
macdonald
et
al
marrack
et
al
mhc
gene
polymorph
human
gene
allel
known
feb
import
increas
rang
respons
differ
individu
mount
human
polymorph
result
concentr
amino
acid
substitut
peptidebind
groov
human
leukocyt
antigen
hla
human
mhc
system
molecul
produc
variabl
peptid
bind
present
cell
macdonald
et
al
year
group
investig
possibl
function
classif
hla
polymorph
base
peptidebind
specif
found
major
hla
allel
class
ii
could
group
differ
supertyp
pure
basi
similar
peptid
bind
specif
lund
et
al
suggest
major
major
human
popul
cover
hla
supertyp
differ
member
supertyp
bind
similar
peptid
promiscu
peptid
present
tcell
sett
et
al
latest
develop
show
evid
presenc
immunolog
hotspot
srinivasan
et
al
antigen
immunolog
hotspot
defin
antigen
region
possess
multipl
promiscu
peptid
supertyp
specif
area
research
rais
prospect
identifi
key
pathogen
antigen
possess
immunolog
hotspot
best
candid
vaccin
design
provid
protect
popul
level
irrespect
ethnic
humor
respons
involv
antibodi
produc
bcell
recogn
linear
conform
bcell
epitop
surfac
pathogen
conform
neutral
epitop
primari
focu
variou
vaccin
research
protect
humor
respons
howev
unlik
linear
bcell
epitop
tcell
epitop
reliabl
comput
tool
predict
conform
epitop
limit
kulkarnikal
et
al
zhang
et
al
pathogen
last
decad
wit
rapid
expans
sequenc
data
dispos
stem
genom
proteom
approach
enabl
analysi
map
key
antigen
potenti
target
protect
immun
respons
genom
sequenc
larg
number
pathogen
threaten
public
health
complet
impend
complet
exampl
whole
genom
virus
sequenc
deposit
major
public
databas
entrez
genom
see
relev
websit
section
data
deriv
genomeproteom
sequenc
relat
project
particular
speci
pathogen
west
nile
viru
miss
gap
toward
develop
vaccin
effect
major
variant
current
known
within
pathogen
speci
probabl
novel
one
yet
emerg
koo
et
al
vaccin
much
superior
current
gener
vaccin
sole
base
singl
antigen
provid
protect
certain
variant
pathogen
therefor
might
elicit
narrow
breadth
respons
provid
protect
remain
divers
variant
pathogen
speci
doolan
made
signific
progress
understand
process
host
involv
mount
immun
respons
howev
still
far
good
understand
natur
complex
pathogen
good
start
point
would
util
pathogen
genomicproteom
data
studi
sequenc
divers
identifi
antigen
contain
conserv
variabl
immunolog
hotspot
fulli
realiz
promis
avail
dataset
studi
would
requir
develop
appropri
technolog
systemat
convert
genomicproteom
data
protect
vaccin
recent
systemat
genomewid
approach
identifi
key
antigen
pathogen
speci
numer
variant
sequenc
pathogen
report
rizwan
et
al
goodswen
et
al
vivona
et
al
del
tordello
et
al
maria
et
al
doolan
raman
et
al
koo
et
al
select
key
antigen
repres
minim
repres
set
target
sequenc
requir
provid
immun
major
exist
variant
particular
pathogen
speci
bioinformat
interdisciplinari
field
essenti
analysi
interpret
complex
larg
quantiti
biolog
data
gener
function
studi
high
throughput
technolog
use
propos
next
set
experi
importantli
deriv
better
understand
biolog
process
state
number
pathogen
sequenc
data
public
databas
increas
rapidli
howev
experiment
approach
studi
larg
data
pool
develop
immun
intervent
timeconsum
costli
almost
impract
combin
bioinformat
experiment
approach
possibl
select
key
experi
help
optim
experiment
design
comput
algorithm
increasingli
use
speedup
process
knowledg
discoveri
help
identifi
critic
experi
test
hypothesi
built
upon
result
comput
screen
number
success
exampl
applic
comput
model
studi
immunolog
problem
describ
exampl
illustr
power
comput
approach
complex
problem
involv
potenti
vast
dataset
potenti
bias
error
discrep
revers
vaccinolog
bottomup
genom
approach
success
appli
develop
vaccin
pathogen
previous
suit
develop
verniko
rappuoli
covacci
rappuoli
del
tordello
et
al
prerequisit
approach
sequenc
data
target
pathogen
act
input
variou
bioinformat
algorithm
predict
put
antigen
like
success
vaccin
target
candid
valid
small
number
key
experi
lab
approach
success
appli
develop
univers
vaccin
group
b
streptococcu
maion
et
al
vaccin
candid
menb
pizza
et
al
among
other
rappuoli
covacci
revers
vaccinolog
promis
method
highthroughput
discoveri
candid
vaccin
target
potenti
mirror
dynam
antigen
divers
target
pathogen
popul
includ
divers
interact
partner
immun
system
howev
big
challeng
end
need
understand
vaccin
develop
cover
antigen
divers
develop
systemat
approach
ration
screen
pathogen
data
select
candid
vaccin
target
cover
divers
year
number
bioinformat
pipelin
design
predict
vaccin
candid
rapidli
effici
vacsol
rizwan
et
al
nerv
vivona
et
al
vacce
goodswen
et
al
exampl
pipelin
proteom
bacteri
eukaryot
pathogen
pipelin
highli
configur
scalabl
zaharieva
et
al
includ
multipl
step
integr
variou
algorithm
analysi
comparison
shortlist
candid
vaccin
target
rank
priorit
toward
experiment
valid
pipelin
expect
improv
vaccin
target
discoveri
process
gener
characterist
desir
candid
vaccin
target
highli
conserv
ii
pathogenspecif
iii
import
structurefunct
iv
immunerelev
v
antigen
similar
circul
strain
highli
conserv
target
less
like
mutat
escap
immun
recognit
particularli
import
structur
function
suggest
robust
histor
conserv
high
conserv
also
reduc
possibl
alteredpeptid
ligand
apl
effect
variant
epitop
pathogen
speci
sloanlancast
allen
evavold
et
al
rothman
variant
may
also
origin
pathogen
particular
cocircul
coinfect
pathogen
interest
belong
famili
vaccin
design
epitop
common
pathogen
could
either
use
induc
crossprotect
detriment
induc
alteredligand
effect
thu
potenti
vaccin
target
analyz
specif
target
pathogen
definit
viru
speciesspecif
vaccin
target
expand
exclud
one
amino
acid
mismatch
human
sequenc
order
avoid
possibl
molecular
mimicri
antigen
mismatch
vaccin
circul
strain
shown
increas
risk
diseas
outbreak
compar
immun
use
ident
strain
park
et
al
thu
import
assess
extent
antigen
ident
candid
vaccin
target
circul
strain
typic
gener
semiautom
comput
framework
compris
three
key
compon
data
collect
data
process
data
analysi
khan
khan
khan
et
al
fig
illustr
workflow
framework
fig
provid
noncomprehens
list
commonli
use
tool
data
collect
would
involv
user
provid
set
sequenc
align
unalign
pathogen
interest
analysi
sequenc
could
singl
protein
dataset
multipl
complet
proteom
addit
compar
analys
sequenc
perform
subtypesgroup
pathogen
sequenc
retriev
public
repositori
primari
specialist
databas
ncbi
entrez
protein
databas
ncbi
resourc
coordin
influenza
research
databas
ird
zhang
et
al
respect
user
also
provid
sequenc
deriv
experiment
work
avail
public
databas
typic
download
data
would
compris
fulllength
partial
sequenc
correspond
metadata
data
process
would
involv
remov
duplic
sequenc
dataset
compar
analysi
merg
input
sequenc
requir
prior
align
step
multipl
sequenc
align
carri
use
exist
tool
robust
deal
larg
sequenc
data
siever
et
al
katoh
et
al
edgar
et
al
clustal
omega
mafft
muscl
probcon
output
align
qualiti
manual
inspect
error
andor
misalign
common
deal
partial
sequenc
henceforth
data
would
readi
analys
involv
perform
divers
analysi
measur
entropi
valu
heini
et
al
hu
et
al
khan
et
al
koo
et
al
quantifi
variant
motif
userdefin
kmer
posit
align
result
analys
plot
output
user
provid
holist
view
divers
includ
variant
distribut
user
defin
prefer
conserv
threshold
select
highli
conserv
sequenc
select
sequenc
analyz
distribut
variant
natur
khan
et
al
koo
et
al
includ
match
human
protein
enabl
identif
pathogen
specif
highli
conserv
sequenc
robust
natur
histor
conserv
assess
perform
function
structur
analysi
sprenger
et
al
hung
link
wizemann
et
al
sachdeva
et
al
et
al
tang
et
al
maria
et
al
relev
identifi
potenti
candid
vaccin
target
use
current
circul
strain
assess
measur
incid
candid
target
correspond
sequenc
recent
strain
viru
interest
antigen
immunogen
candid
sequenc
predict
assess
immun
relev
experiment
valid
includ
match
predict
epitop
report
epitop
public
databas
immun
epitop
databas
iebd
syfpeithi
perform
quantit
measur
preselect
candid
peptid
gener
synthet
construct
test
immunogen
use
hla
transgen
anim
model
express
specif
hla
allel
rosloniec
et
al
lefranc
et
al
khan
bioinformat
tool
facilit
process
epitop
map
identifi
peptid
potenti
elicit
tcell
respons
bind
epitop
hla
antigen
highli
allelespecif
core
peptidebind
motif
usual
often
defin
experiment
number
hla
class
class
ii
allel
incorpor
comput
algorithm
allow
predict
candid
hlabind
epitop
silico
protein
sequenc
parker
et
al
rammense
et
al
sturniolo
et
al
zhang
et
al
nielsen
et
al
karosien
et
al
paul
et
al
paul
et
al
andreatta
et
al
andreatta
nielsen
pro
et
al
troll
et
al
abelin
et
al
jurtz
et
al
fleri
et
al
recent
quantifi
predict
featur
tcrab
bind
hlaepitop
complex
also
describ
birnbaum
et
al
dash
et
al
glanvil
et
al
gee
et
al
two
main
categori
special
immunoinformat
tool
avail
predict
mhc
bind
peptidesmethod
base
identifi
pattern
sequenc
bind
peptid
employ
threedimension
structur
model
peptidemhc
interact
liljeroo
et
al
patternbas
method
includ
bind
motif
quantit
matric
decis
tree
artifici
neural
network
ann
hidden
markov
model
hmm
support
vector
machin
svm
among
other
contrast
structur
base
method
theoret
root
includ
homolog
model
dock
thread
techniqu
dominguez
et
al
de
vri
et
al
agostino
et
al
khan
ranganathan
liljeroo
et
al
although
less
accur
pattern
base
approach
overrepres
literatur
due
higher
complex
develop
longer
comput
time
accur
structurebas
approach
ranganathan
maria
et
al
includ
sheer
differ
avail
linear
versu
structur
data
given
sequenc
typic
possibl
overlap
later
peptid
sequenc
extract
epitop
predict
hla
class
class
ii
allel
perform
use
benchmark
predict
model
includ
hla
class
epitop
artifici
neural
network
ann
train
netmhcpan
version
troll
et
al
jurtz
et
al
hla
class
ii
epitop
netmhciipan
karosien
et
al
andreatta
nielsen
allelespecif
consensu
percentil
rank
algorithm
queri
immun
epitop
databas
analysi
resourc
iedb
tool
combin
nnalign
smmalign
comblibsturniolo
paul
et
al
b
addit
proteasom
cleavag
hakenberg
et
al
nussbaum
et
al
nielsen
et
al
tap
bind
predict
zhang
et
al
bhasin
et
al
bhasin
raghava
perform
prioriti
rank
sever
tool
netctl
larsen
et
al
integr
variou
predict
one
predict
hla
supertyp
group
hla
allel
similar
peptid
bind
specif
potenti
crossreact
self
epitop
may
search
within
human
proteom
use
blastblat
align
tool
kent
altschul
et
al
revers
vaccinolog
immunoinformat
approach
wide
appli
viral
vaccin
design
influenza
viru
chikungunya
viru
zika
viru
other
gupta
et
al
et
al
includ
parasit
damfo
et
al
bacteria
zahroh
et
al
rappuoli
khan
et
al
develop
bioinformat
pipelin
denv
prove
gener
success
appli
sever
virus
wnv
koo
et
al
close
rel
denv
khan
et
al
number
virus
hu
et
al
among
other
provid
novel
gener
approach
formul
peptidebas
vaccin
target
broad
divers
pathogen
applic
human
popul
larg
methodolog
signific
contribut
field
revers
vaccinolog
enabl
systemat
screen
analys
pathogen
data
would
otherwis
imposs
carri
experiment
due
mani
pathogen
sequenc
high
viral
divers
variat
immun
system
among
individu
extens
polymorph
hla
approach
therefor
significantli
reduc
effort
cost
experiment
provid
systemat
screen
analys
pathogen
proteom
raman
et
al
khan
et
al
koo
et
al
hu
et
al
analyz
larg
number
dengu
denv
west
nile
viru
wnv
clade
b
sequenc
respect
retriev
ncbi
entrez
protein
databas
tabl
sequenc
align
overlap
nonam
amino
acid
posit
viral
proteom
possibl
core
bind
domain
human
leukocyt
antigen
molecul
tcell
receptor
quantit
analyz
mean
entropi
denv
nonam
sequenc
low
rang
within
serotyp
even
lower
wnv
rang
highest
clade
b
subtyp
entropi
gener
measur
divers
data
provid
holist
overview
viral
divers
across
proteom
accordingli
incid
variant
preval
index
sequenc
align
nonam
posit
lowest
wnv
intra
highest
clade
b
intra
variant
incid
within
denv
serotyp
compar
wnv
serotyp
closer
clade
b
subtyp
fortyfour
sequenc
pandenv
sequenc
ident
record
denv
sequenc
repres
denv
polyprotein
length
proport
much
higher
wnv
complet
conserv
incid
notabl
similar
incid
level
incid
denv
although
panclad
intra
clade
b
proteom
highli
conserv
proport
conserv
sequenc
immunerelev
show
invers
relationship
denv
match
class
ii
report
epitop
wnv
match
class
ii
report
epitop
clade
b
match
class
ii
report
epitop
khan
et
al
highlight
conserv
analysi
go
beyond
speci
interest
extend
speci
evolutionarili
relat
may
act
variant
conserv
epitop
identifi
step
necessari
identifi
conserv
epitop
sequenc
pathogen
specif
none
minim
number
variant
sequenc
within
across
pathogen
speci
variant
epitop
hypothes
caus
deleteri
immun
respons
mani
conserv
sequenc
match
nine
consecut
amino
acid
mani
flavivirus
famili
wnv
denv
deltavirus
genu
relat
virus
leav
pathogen
specif
conserv
sequenc
denv
wnv
clade
b
subtyp
respect
accord
world
health
organ
noninfecti
diseas
especi
chronic
diseas
lead
disabl
henc
diseas
cancer
obes
neurodegen
diseas
addict
other
becom
recent
focu
vaccin
develop
barrett
cancer
common
noninfecti
diseas
lead
death
worldwid
due
advanc
technolog
success
silico
method
infecti
diseas
vaccin
design
comput
approach
appli
studi
cancer
vaccin
design
exampl
vaccimm
develop
bioinformat
approach
simul
peptid
vaccin
cancer
therapi
von
eichborn
et
al
addit
model
approach
use
comput
biolog
sim
triplex
metastasim
model
import
understand
molecular
interact
cellular
molecular
level
pappalardo
et
al
sankar
et
al
adekiya
et
al
report
recent
exampl
studi
includ
bioinformat
analysi
cancer
vaccin
develop
futur
vaccin
minimalist
approach
focus
key
part
pathogen
region
contain
epitop
cover
antigen
divers
thu
target
immunolog
similar
subgroup
human
popul
multipl
pathogen
variant
evid
trend
observ
evolut
vaccin
strategi
seen
shift
whole
organ
recombin
protein
toward
ultim
minimalist
vaccinolog
peptideepitopemultiepitop
base
vaccin
minimalist
approach
also
expect
cover
safeti
concern
associ
tradit
vaccin
approach
use
whole
organ
sett
fike
dertzbaugh
vector
vaccin
suitabl
combin
immun
produc
recombin
dna
technolog
contain
multival
minim
antigen
protect
multipl
infect
consid
futur
vaccinolog
kutzler
weiner
futur
bring
increas
integr
vaccin
research
advanc
immunolog
molecular
biolog
genom
proteom
informat
highthroughput
instrument
collect
defin
emerg
field
vaccinom
hail
respons
next
golden
age
vaccinolog
poland
et
al
awar
novel
technolog
possibl
vaccin
research
also
expect
grow
futur
vaccinolog
base
detail
understand
immun
function
optim
stimul
immun
respons
use
adjuv
precis
map
ration
select
immun
target
achiev
vaccin
develop
routin
conduct
largescal
function
studi
support
genom
proteom
informat
techniqu
prior
clinic
trial
provid
increas
rang
immun
target
vaccin
design
author
expect
emerg
new
gener
vaccin
personalis
genet
makeup
human
popul
diseas
agent
summari
vaccinolog
experi
rapid
progress
eventu
deliv
benefit
patient
improv
diagnosi
treatment
prevent
diseas
see
also
comput
pipelin
workflow
bioinformat
extract
immun
epitop
inform
hostpathogen
interact
natur
languag
process
approach
bioinformat
